NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The tumor microenvironment (TME) in pancreatic ductal adenocarcinoma (PDA) is characterized by immune tolerance, which enables disease to progress unabated by adaptive immunity. However, the drivers of this tolerogenic program are incompletely defined. In this study, we found that NLRP3 promotes expansion of immune-suppressive macrophages in PDA. NLRP3 signaling in macrophages drives the differentiation of CD4+ T cells into tumor-promoting T helper type 2 cell (Th2 cell), Th17 cell, and regulatory T cell populations while suppressing Th1 cell polarization and cytotoxic CD8+ T cell activation. The suppressive effects of NLRP3 signaling were IL-10 dependent. Pharmacological inhibition or deletion of NLRP3, ASC (apoptosis-associated speck-like protein containing a CARD complex), or caspase-1 protected against PDA and was associated with immunogenic reprogramming of innate and adaptive immunity within the TME. Similarly, transfer of PDA-entrained macrophages or T cells from NLRP3−/− hosts was protective. These data suggest that targeting NLRP3 holds the promise for the immunotherapy of PDA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In those cases, IL-1β is the key player, acting as pro-inflammatory, tumor-promoting trigger [126,127,128,129,130].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
The Epidemiology of Pancreatitis and Pancreatic Cancer
Yadav, D., & Lowenfels, A. B. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.068 · Cited by 1,974 · cited 1×
“1711 IntroductIon Pancreatic ductal adenocarcinoma (PDA) is a devastating disease in which the mortality rate approaches the incidence rate (Yadav and Lowenfels, 2013).”
BackgroundPancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R. W., Lankisch, P. G., Andersen, J. R., Dimagno, E. P., Andren-Sandberg, A., & Domellof, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,757
Cited by
Items 201–259 of 259
NLRPs and tumor: research progress from molecular mechanisms to clinical applications
Song, L., Cao, Y., & Tao, Y. (2025) · Oncogene · doi:10.1038/s41388-025-03642-3 · Cited by 4
Németh, K., Mezei, E., Vörös, J., Borka, K., Pesti, A., Kenessey, I., Kiss, A., & Budai, A. (2025) · The Journal of Pathology Clinical Research · doi:10.1002/2056-4538.70019 · Cited by 4
Yu, J., Li, H., Wang, J., Chen, X., Lu, L., Wei, Y., Wang, Y., & Mo, S. (2023) · Journal of Cancer · doi:10.7150/jca.79905 · Cited by 4
The unseen architects of metastasis: coagulation factors in pre-metastatic niche development
Huang, H., Lu, X., Liu, Y., Zhang, Y., Zhan, J., Zeng, W., Sun, C., Li, B., Zhang, Y., Wang, Q., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02727-0 · Cited by 3
NLRP3 participates in the differentiation and apoptosis of PMA‑treated leukemia cells
Wang, Y., Xin, C., Li, X., Chang, X., & Jiang, R. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13039 · Cited by 3
Li, B., Liu, Y., Chen, D., & Sun, S. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.109918 · Cited by 3
Microbial marauders: pancreatic microbiota and its impact on carcinogenesis
Thomas, R. M., & Zajac‐Kaye, M. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.10.34 · Cited by 3
Boccia, T., Fattori, V., da Silva, M. D. V., Asquith, N. L., Pan, W., Rogers, M. S., Zanoni, I., & Cuenca, A. G. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf206 · Cited by 2
Mitchell, D. K., Brewster, K., Jiang, L., Mang, H. E., Bessler, W., Li, X., Lu, Q., Qian, S., York, E., Morrow, S. K., et al. (2026) · Science Advances · doi:10.1126/sciadv.ady8382 · Cited by 2
Therapeutic opportunities targeting the NLRP3 inflammasome
Hooftman, A., Zotta, A., & O'Neill, L. A. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00035-9 · Cited by 2
Nagai-Singer, M. A. (2023) · VTechWorks (Virginia Tech) · Cited by 2
Chen, Z., Guan, D., Wang, Y., & Gou, Y. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.06.004 · Cited by 1
LncRNAs in inflammasome regulation: Orchestrating cancer signaling and chemoresistance
Mukhlif, M. Y., Mahmood, S. H., Khalaf, A. A., Sanghvi, G. V., Ballal, S., Singh, A., Sabarivani, A., Mishra, S. S., Mustafa, Y. F., & Yasin, H. A. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152455 · Cited by 1
Chey, Y. C. J., Kashgari, B., McLeod, L., Radford, G., Gearing, L. J., Dawson, R., Kharbanda, M., Lundy, J., Croagh, D. G., Girard-Guyonvarc’h, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69398-w · Cited by 1
Gupta, S., Agrawal, N., Siddiqui, M. A., Jaiswal, M., & Lanjhiyana, S. K. (2026) · Journal of Human Nutrition and Probiotics · doi:10.2174/0126666499397170251204233934 · Cited by 1
Rébé, C., Perrichet, A., & Ghiringhelli, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00009-8 · Cited by 1
Innate αβ T-Cells Mediate Anti-Tumor Immunity by Orchestrating Immunogenic Macrophage Programming
Mishra, A., Barry-Hundeyin, M., Kurz, E., & Miller, G. (2019) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2019.08.586 · Cited by 1
Self-citationRole of the Inflammasome in Cancer
Terlizzi, M., Colarusso, C., Pinto, A., & Sorrentino, R. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_15 · Cited by 1
Li, L., He, Q. H., Tao, Z., Zhang, R., Cui, Y., & Qian, L. (2022) · PubMed · Cited by 1
The Role of Inflammasome in Cancers and Potential Therapeutic Targets
Farhangnia, P., Safdarian, A. R., & Akbarpour, M. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_70-1 · Cited by 1
Boccia, T., Pan, W., Fattori, V., Cervantes‐Díaz, R., Rogers, M. S., Zanoni, I., & Cuenca, A. G. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4977885 · Cited by 1
Neto, C. R., & da Costa, L. H. A. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The interconnection between the inflammasome and breast cancer
Balahura, L.-R., Dinescu, S., & Costache, M. (2020) · Reviews in Biological and Biomedical Sciences · doi:10.31178/rbbs.2020.3.1.3
Pancreatic Cancer Immuno-oncology in the Era of Precision Medicine
Hegde, S. (2020) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-020-01192-6
The effect of NLRP3 on tumors based on pan-cancer researchPreprint
Tang, D., Li, W., Xu, Z., Jiang, S., & Fang, K. (2021) · Research Square · doi:10.21203/rs.3.rs-148628/v1
A Novel Prognostic Model Based On Cytosolic DNA Sensing-Related Gene Signature for Pancreatic CancerPreprint
Xu, C., Yang, K.-S., Zhao, S., & Lv, J. (2021) · Research Square · doi:10.21203/rs.3.rs-877931/v1
Dutt, A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732882487.793545488
Tang, Y., Zhang, C., Ye, C., Tian, K., Zeng, J., Cheng, S., Zeng, W., Yang, B., Liu, Y., & Yu, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15693
Research Progress on the Mechanism and Treatment of Pyroptosis in Brain Glioma
Han, X., Zhou, J., Liu, S., Yang, S., & Sui, A. (2023) · Cancer Research Journal · doi:10.11648/j.crj.20231102.15
Systemic Oncosphere: Host Innate Immune System
Saw, P. E., & Song, E. (2023) · Springer eBooks · doi:10.1007/978-981-99-1183-7_19
Lillo, S. (2023) · theses.fr (ABES) · doi:10.70675/49be81c2z656fz400dzbc64z391cf8330a65
CD301b lectin expression in the breast tumor microenvironment augments tumor growthPreprint
Ozdilek, A., Paschall, A. V., Nawaz, Z., Niyas, A. M. M., & Avci, F. Y. (2024) · Research Square · doi:10.1101/2024.03.13.584829
Coudereau, R. (2023) · theses.fr (ABES) · doi:10.70675/d8dd405fz1435z4d72z9191z26e62d4202f9
Parikh, M., Soni, A., & Gandhi, T. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00019-x
Mikołajczyk, A., Wardak, A., Głuszek, S., & Adamus-Białek, W. (2025) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.2478/am-2025-0007
The Role of Inflammasome in Cancers and Potential Therapeutic Targets
Farhangnia, P., Safdarian, A. R., & Akbarpour, M. (2025) · Springer eBooks · doi:10.1007/978-3-032-00771-1_70
Somefun, K. (2025) · University Library of Skövde (University of Skövde)
Interleukin-1 receptor type 1 in pancreatic cancer progression and metastasis: a review
Saito, K., Matsuo, Y., Denda, Y., Nonoyama, K., Murase, H., Kato, T., Yamakawa, Y., Sato, T., Sagawa, H., Ogawa, R., et al. (2026) · International Journal of Clinical Oncology · doi:10.1007/s10147-026-03000-7
Implication de l'inflammasome NLRP3 dans la sécrétion non conventionnelle de la protéine FADD
Mouasni, S. (2018) · theses.fr (ABES) · doi:10.70675/8623f190zbb94z44b7z8b70zd93fa9be484d
Inflammation, aging and chronic diseases : implication of inflammasomes
Guerville, F. (2023) · theses.fr (ABES) · doi:10.70675/eac3286czda71z4606z9c90z3d3efeaf1afe
Tumor glycosylation engages CD301b-mediated myeloid regulation in breast cancerPreprint
Ozdilek, A., Paschall, A. V., Nawaz, F. Z., Niyas, A. M. M., & Avci, F. Y. (2026) · Research Square · doi:10.21203/rs.3.rs-9347231/v1
The bidirectional inflammasome–lymphocyte axis in immune regulation
Kwon, Y., Lim, S. A., & Lee, S. (2026) · Trends Open · doi:10.1016/j.treopn.2026.05.002
The Role of The NLRP3 Inflammasome in Preeclampsia and Implantation Failure: A Molecular Review
Suryawinata, A. B., Darmayani, M. T., & Suhargo, L. (2026) · Chulalongkorn Medical Journal · doi:10.56808/2673-060x.5725
Yu, S., Lee, S. H., Choi, M. S., & Choi, J. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102050
Prognostic significance of NLRP-3 expression in solid cancers: a systematic review and meta-analysis
Thakur, N., Alamgeer, M., Kumar, M., Luong, Q., Abdul‐Ghafar, J., Arulananda, S., Mansell, A., & Gough, D. J. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2712701
Hou, Y., & Tan, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1942345
I macrofagi IL-1b+ alimentano l'infiammazione patogena nel tumore al pancreas
Vittoria, F. M. (n.d.) · Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele
Fusobacterium nucleatum mediated crosstalk drives cisplatin resistance in head and neck cancer
Khan, M. D., Ali, M. A., Chaudhry, A., Ahsan, A., & Ahmad, I. (2026) · Oncology · doi:10.1159/ocl/aebag021
The Senescence-Malignancy Axis: An Inflammaging Perspective
Patrono, I., Sonnessa, M., Trerotola, M., Giudetti, A. M., Summa, S. D., Zito, F. A., Saponaro, C., & Vergara, D. (2026) · Antioxidants · doi:10.3390/antiox15101357
Zhou, M., Wang, G., Li, Y., Lu, W., Wang, B., Fan, X., Sun, Y., & Wang, C. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.103087
Hu, J., Song, Y., Cai, X., Halina, H., Qiao, K., Lu, J., Yin, C., & Gao, F. (2023) · doi:10.3389/fendo.2023.1120216.s001
Lang, C., Roy, S., Wang, Y., Graves, D., Xu, Y., Serezani, C. H., Korrer, M., & Kim, Y. J. (2022) · doi:10.3389/fimmu.2022.993771.s002
Huang, X., Wang, Y., Yang, W., Dong, J., & Li, L. (2022) · doi:10.3389/fnut.2022.974896.s001
Supporting information 2 of NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells
Nagai-Singer, M. A., Morrison, H. A., Woolls, M. K., Leedy, K., Imran, K. M., Tupik, J. D., & Allen, I. C. (2023) · doi:10.3389/fonc.2023.1155831.s002
Metadata
- Authors
- Daley, D., Mani, V. R., Mohan, N., Akkad, N., Pandian, G. S. D. B., Savadkar, S., Lee, K. B., Torres-Hernandez, A., Aykut, B., Diskin, B., Wang, W., Farooq, M. S., Mahmud, A. I., Werba, G., Morales, E. J., Lall, S., Wadowski, B. J., Rubin, A. G., Berman, M. E., Narayanan, R., Hundeyin, M., & Miller, G.
- Affiliations
- New York University (US)
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, NY 10016 1
- Corresponding author
- Miller, George
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-04-25
- Volume
- 214
- Issue
- 6
- Pages
- 1711-1724
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5461004
- OpenAlex
- W2608757343
- Cited by
- 244
- References
- 49
- Citations by year
- 2026: 11 · 2025: 28 · 2024: 24 · 2023: 44 · 2022: 42 · 2021: 29 · 2020: 22 · 2019: 28 · 2018: 12 · 2017: 4
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA168611, CA155649, CA206105)
- Department of Defense
- Lustgarten Foundation
- American Association for Cancer Research
- Pancreatic Cancer Action Network
- Hirshberg Foundation for Pancreatic Cancer Research
- Irene and Bernard Schwartz Fellowship in Gastrointestinal Oncology
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- NLRP3 inflammasome, pancreatic ductal adenocarcinoma, tumor microenvironment, tumor-associated macrophages, IL-10, Th17 cells, regulatory T cells, Th2 cells, CD8+ T cell activation, ASC, caspase-1, immunotherapy, macrophage reprogramming
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Cell Differentiation, Humans, Immunosuppression Therapy, Macrophages, Mice, Inbred C57BL, Pancreatic Neoplasms, T-Lymphocytes, Signal Transduction, Gene Deletion, Caspase 1, Carcinoma, Pancreatic Ductal, Cell Proliferation, Apoptosis Regulatory Proteins, CARD Signaling Adaptor Proteins, Nod2 Signaling Adaptor Protein, Adaptive Immunity, Pancreatic Stellate Cells, Tumor Microenvironment, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.